District Court Upholds SEC Conflict Minerals Rule

The following post comes to us from Adam M. Givertz, partner in the Corporate Department at Paul, Weiss, Rifkind, Wharton & Garrison LLP, and is based on a Paul Weiss client memorandum by Mr. Givertz, Christopher J. Cummings, Andrew J. Foley, Edwin S. Maynard, and Stephen C. Centa.

On July 23, 2013, the District Court for the District of Columbia upheld Rule 13p-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act“), which was promulgated by the Securities and Exchange Commission (the “SEC”) pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act. Rule 13p-1 requires issuers to disclose their use of coltan, cassiterite, gold and wolframite originating in the Democratic Republic of the Congo (the “DRC”) or an adjoining country (“Conflict Minerals”) in their manufactured products.

The plaintiffs — the National Association of Manufacturers, the Chamber of Commerce, and the Business Roundtable (collectively, the “Plaintiffs”) — challenged Rule 13p-1 on several grounds. First, the Plaintiffs claimed that Rule 13p-1 was “arbitrary and capricious” within the meaning of the Administrative Procedure Act (the “APA”) and, therefore, unlawful. Specifically, the Plaintiffs argued that the SEC failed to adequately analyze the humanitarian costs and benefits of Rule 13p-1. The District Court found this contention to lack merit as the Court interpreted the Exchange Act to only require that the SEC “consider the impact that a rule or regulation may have on various economic-related factors—efficiency, competition, and capital formation” and not to “consider whether [Rule 13p-1] would actually achieve the humanitarian benefits identified by Congress.” The District Court also rejected the Plaintiffs’ argument that the SEC’s estimates of the costs of implementing the rule were flawed, finding that the SEC’s methodology in reaching such estimates to be “eminently appropriate.”

The Plaintiffs also claimed that Rule 13p-1 was arbitrary and capricious because the SEC improperly (i) failed to create a de minimis exception from reporting in cases where issuers use only small amounts of conflict minerals in their products, (ii) required reporting from any issuer that believes that it uses conflict minerals that may have originated in the DRC or an adjoining country and (iii) subjected issuers that contract to manufacture products that contain conflict minerals to Rule 13p-1. With respect to each of these arguments, the District Court found that the SEC acted reasonably and within its authority. Lastly, the District Court upheld the SEC’s decision to permit different phase-in periods for Rule 13p-1, depending on the size of the issuer, as also reasonable under the APA.

The Plaintiffs also claimed that Rule 13p-1 improperly compelled “burdensome and stigmatizing speech” in violation of the First Amendment because Rule 13p-1 could obligate companies to publicly state, both on their websites and in SEC filings, that certain of their products are not “DRC conflict free.” The District Court rejected the Plaintiffs’ First Amendment argument, concluding that Rule 13p-1 survived scrutiny, in part, because Rule 13p-1 advanced Congress’s substantial interest “in promoting peace and security in and around the DRC.”

While the Plaintiffs may appeal the District Court’s decision to the Court of Appeals for the District of Columbia, issuers should continue to prepare to comply with Rule 13p-1, as Rule 13p-1 remains in effect and will require initial reports to be filed with the SEC by May 31, 2014.

Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

  • Subscribe

  • Cosponsored By:

  • Supported By:

  • Programs Faculty & Senior Fellows

    Lucian Bebchuk
    Alon Brav
    Robert Charles Clark
    John Coates
    Alma Cohen
    Stephen M. Davis
    Allen Ferrell
    Jesse Fried
    Oliver Hart
    Ben W. Heineman, Jr.
    Scott Hirst
    Howell Jackson
    Wei Jiang
    Reinier Kraakman
    Robert Pozen
    Mark Ramseyer
    Mark Roe
    Robert Sitkoff
    Holger Spamann
    Guhan Subramanian

  • Program on Corporate Governance Advisory Board

    William Ackman
    Peter Atkins
    Joseph Bachelder
    John Bader
    Allison Bennington
    Richard Breeden
    Daniel Burch
    Richard Climan
    Jesse Cohn
    Isaac Corré
    Scott Davis
    John Finley
    Daniel Fischel
    Stephen Fraidin
    Byron Georgiou
    Larry Hamdan
    Carl Icahn
    David Millstone
    Theodore Mirvis
    James Morphy
    Toby Myerson
    Barry Rosenstein
    Paul Rowe
    Rodman Ward